Validation of a breast cancer risk prediction model developed for Black women.

PubWeight™: 1.46‹?› | Rank: Top 5%

🔗 View Article (PMC 3691941)

Published in J Natl Cancer Inst on February 14, 2013

Authors

Deborah A Boggs1, Lynn Rosenberg, Michael J Pencina, Lucile L Adams-Campbell, Julie R Palmer

Author Affiliations

1: Slone Epidemiology Center, 1010 Commonwealth Ave, Boston, MA 02215, USA. dboggs@bu.edu

Articles cited by this

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst (1989) 19.87

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst (2001) 5.97

Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst (1999) 5.92

Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst (2005) 5.52

Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst (2004) 4.57

Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst (2007) 3.93

Mean age of mother, 1970-2000. Natl Vital Stat Rep (2002) 2.71

Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst (2008) 2.64

Predicting risk of breast cancer in postmenopausal women by hormone receptor status. J Natl Cancer Inst (2007) 2.36

Breast cancers among very young premenopausal women (United States). Cancer Causes Control (2003) 1.80

Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev (2011) 1.71

Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer. Nat Clin Pract Oncol (2007) 1.50

Breast cancer risk factors among black women and white women: similarities and differences. Am J Epidemiol (1992) 1.31

Effect of changing breast cancer incidence rates on the calibration of the Gail model. J Clin Oncol (2010) 1.05

Articles by these authors

General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42

Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology (2010) 14.07

Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39

Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA (2002) 10.03

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70

Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27

Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96

Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA (2007) 6.95

Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med (2011) 5.94

Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med (2004) 5.65

One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA (2009) 5.52

Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst (2005) 5.52

Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA (2013) 4.81

Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA (2003) 4.72

Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med (2008) 4.63

A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med (2008) 4.61

On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med (2011) 4.34

Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch Intern Med (2008) 4.03

Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation (2007) 3.99

Long-term trends in the incidence of heart failure after myocardial infarction. Circulation (2008) 3.52

Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation (2006) 3.41

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37

Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation (2009) 3.23

Statin use and the risk of 10 cancers. Epidemiology (2007) 3.17

Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol (2004) 3.07

Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med (2010) 3.05

Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide. Ann Intern Med (2014) 3.00

Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med (2008) 2.90

Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst (2011) 2.84

Air pollution and incidence of hypertension and diabetes mellitus in black women living in Los Angeles. Circulation (2012) 2.78

Recent trends in use of herbal and other natural products. Arch Intern Med (2005) 2.65

Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol (2008) 2.64

Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease. JAMA (2011) 2.57

Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev (2013) 2.56

Prevalence and characteristics of opioid use in the US adult population. Pain (2008) 2.49

Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol (2012) 2.47

Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc (2013) 2.47

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45

Reclassification calculations for persons with incomplete follow-up. Ann Intern Med (2010) 2.35

Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. Cancer Causes Control (2008) 2.35

Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology (2005) 2.33

Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation (2010) 2.32

Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation (2011) 2.32

General and abdominal obesity and risk of death among black women. N Engl J Med (2011) 2.27

Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study. BMC Med Genet (2007) 2.25

LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management. J Clin Lipidol (2007) 2.21

Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol (2005) 2.18

Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med (2011) 2.16

Statin use and the risk of breast and prostate cancer. Epidemiology (2002) 2.15

Relative validity of food frequency questionnaire nutrient estimates in the Black Women's Health Study. Ann Epidemiol (2003) 2.11

Socioeconomic status and incidence of type 2 diabetes: results from the Black Women's Health Study. Am J Epidemiol (2010) 2.10

Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care (2010) 2.06

Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA (2005) 2.05

Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in U.S. black women. Diabetes Care (2006) 1.98

Increasing trends in incidence of overweight and obesity over 5 decades. Am J Med (2007) 1.95

Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst (2013) 1.94

Characteristics of Framingham offspring participants with long-lived parents. Arch Intern Med (2007) 1.91

Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community. Circulation (2009) 1.84

A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82

Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control (2010) 1.82

A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circ Cardiovasc Genet (2012) 1.81

Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. Stroke (2011) 1.78

Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation (2009) 1.77

A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev (2007) 1.77

Racial discrimination and breast cancer incidence in US Black women: the Black Women's Health Study. Am J Epidemiol (2007) 1.77

Advance care planning and health care preferences of community-dwelling elders: the Framingham Heart Study. J Gerontol A Biol Sci Med Sci (2008) 1.76

Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study. Circulation (2009) 1.75

Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. JAMA (2010) 1.75

Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure. Circulation (2005) 1.75

Type 2 diabetes and the risk of colorectal adenomas: Black Women's Health Study. Am J Epidemiol (2013) 1.72

A case-control study of oral contraceptive use and incident breast cancer. Am J Epidemiol (2008) 1.72

Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev (2011) 1.71

Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture. JAMA (2013) 1.70

Association of parental heart failure with risk of heart failure in offspring. N Engl J Med (2006) 1.69

Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants. J Am Geriatr Soc (2005) 1.68

Glycemic index, glycemic load, and cereal fiber intake and risk of type 2 diabetes in US black women. Arch Intern Med (2007) 1.67

Estimated risks for developing obesity in the Framingham Heart Study. Ann Intern Med (2005) 1.67

Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.67

Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst (2003) 1.66